La Rosa Holdings Corp. Reports Strong Q1 2025 Growth at Celebration, FL and BF Prime, Puerto Rico Offices Driven by Increased Agent Count, Revenue, and Transactions May 7, 2025
OS Therapies Announces Issuance of U.S. Patent #12,239,738 Protecting Commercial Manufacturing Market Exclusivity for OST-HER2 in Rare Pediatric Cancer Osteosarcoma and Full Listeria Cancer Immunotherapy Platform into 2040 May 7, 2025